The vanilloid agonist resiniferatoxin for interventional-based pain control

Current Topics in Medicinal Chemistry

Volumn 11, Issue 17, 2011, Pages 2171-2179

  Iadarola, Michael J ^a   Mannes, Andrew J ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

A delta fiber; Analgesia; C fiber; Calcium cytotoxicity; Cancer pain; Canine; Capsaicin; Cerebrospinal fluid; Dorsal root ganglion; Hyperalgesia; Intrathecal; Ion channel; Osteosarcoma; Proprioceptor; Spinal cord; Vanilloid receptor

Indexed keywords

CALCIUM; RESINIFERATOXIN; VANILLOID RECEPTOR 1;

DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HYPERALGESIA; NERVE ENDING; NOCICEPTION; NONHUMAN; PAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SPINAL GANGLION;

ANIMALS; CAPSAICIN; DITERPENES; HUMANS; PAIN; STRUCTURE-ACTIVITY RELATIONSHIP; TRPV CATION CHANNELS;

EID: 80052216483     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/156802611796904942     Document Type: Review

References (47)

1. Backonja, M.M.; Malan, T.P.; Vanhove, G.F.; Tobias, J.K. NGX- 4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension. Pain Med., 2010, 11(4) 600-608.
2. Simpson, D.M.; Gazda, S.; Brown, S.; Webster, L.R.; Lu, S.P.; Tobias, J.K.; Vanhove, G.F. Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain. J. Pain Symptom Manage., 2010, 39(6)1053-1064.
3. Derry, S.; Lloyd, R.; Moore, R.A.; McQuay, H.J. Topical capsaicin for chronic neuropathic pain in adults. Cochrane Database Syst. Rev., 2009, 4 CD007393.
4. Yaksh, T.L.; Farb, D.H.; Leeman, S.E.; Jessell, T.M. Intrathecal capsaicin depletes substance P in the rat spinal cord and produces prolonged thermal analgesia. Science, 1979, 206(4417)481-483.
5. Nagy, J.I.; Emson, P.C.; Iversen, L.L. A re-evaluation of the neuro-chemical and antinociceptive effects of intrathecal capsaicin in the rat. Brain Res., 1981, 211(2)497-502.
6. Palermo, N.N.; Brown, H.K.; Smith, D.L. Selective neurotoxic action of capsaicin on glomerular C-type terminals in rat substantia gelatinosa. Brain Res., 1981, 208(2)506-510.
7. Russell, L.C.; Burchiel, K.J. Effect of intrathecal and subepineural capsaicin on thermal sensitivity and autotomy in rats. Pain, 1986, 25(1)109-123.
8. Roh, E.J.; Keller, J.M.; Olah, Z.; Iadarola, M.J.; Jacobson, K.A. Structure-activity relationships of 1.4-dihydropyridines that act as enhancers of the vanilloid receptor 1 (TRPV1). Bioorg. Med. Chem., 2008, 16(20)9349-9358
9. Kárai, L.J.; Russell, J.T.; Iadarola, M.J.; Oláh, Z. Vanilloid receptor 1 regulates multiple calcium compartments and contributes to Ca2+-induced Ca2+ release in sensory neurons. J. Biol. Chem., 2004, 279(16)16377-16387
10. Neubert, J.K.; Karai, L.; Jun, J.H.; Kim, H.S.; Olah, Z.; Iadarola, M.J. Peripherally induced resiniferatoxin analgesia. Pain, 2003, 104(1-2)219-228.
11. Kárai, L.; Brown, D.C.; Mannes, A.J.; Connelly, S.T.; Brown, J.; Gandal, M.; Wellisch, O.M.; Neubert, J.K.; Oláh, Z.; Iadarola, M.J. Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control. J. Clin. Invest., 2004, 113(9)1344-1352
12. Brown, D.C.; Iadarola, M.J.; Perkowski, S.Z.; Erin, H.; Shofer, F.; Kárai, L.; Oláh, Z.; Mannes, A.J. Physiologic and antinociceptive effects of intrathecal resiniferatoxin in a canine bone cancer model. Anesthesiology, 2005, 103(5)1052-1059
13. Tender, G.C.; Walbridge, S.; Olah, Z.; Karai, L.; Iadarola, M.; Oldfield, E.H.; Lonser, R.R. Selective ablation of nociceptive neurons for elimination of hyperalgesia and neurogenic inflammation. J. Neurosurg., 2005, 102(3)522-525
14. Neubert, J.K.; Mannes, A.J.; Karai, L.J.; Jenkins, A.C.; Zawatski, L.; Abu-Asab, M.; Iadarola, M.J. Perineural resiniferatoxin selectively inhibits inflammatory hyperalgesia. Mol. Pain, 2008, 4, 3.
15. Oláh, Z.; Szabo, T.; Kárai, L.; Hough, C.; Fields, R.D.; Caudle, R.M.; Blumberg, P.M.; Iadarola, M.J. Ligand-induced dynamic membrane changes and cell deletion conferred by vanilloid receptor 1. J. Biol. Chem., 2001, 276(14)11021-11030.
16. Oláh, Z.; Kárai, L.; Iadarola, M.J. Anandamide activates vanilloid receptor 1 (VR1) at acidic pH in dorsal root ganglia neurons and cells ectopically expressing VR1. J. Biol. Chem., 2001, 276(33)31163-31170.
17. Iadarola, M.J.; Civelli, O.; Douglass, J.; Naranjo, J.R. Increased spinal cord dynorphin mRNA during peripheral inflammation. In: Progress in Opioid Research, Holaday JW, Law P-L and Herz A (Eds) NIDA Res. Monographs, 1986, 75 406-409.
18. Iadarola, M.J.; Douglass, J.; Civelli, O.; Naranjo, J.R. Differential activation of spinal cord dynorphin and enkephalin neurons during hyperalgesia: evidence using cDNA hybridization. Brain Res., 1988, 455(2)205-212.
19. Iadarola, M.J.; Brady, L.S.; Draisci, G.; Dubner, R. Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioral parameters and opioid receptor binding. Pain, 1988, 35(3)313-326.
20. Caterina, M.J.; Schumacher, M.A.; Tominaga, M.; Rosen, T.A.; Levine, J.D.; Julius, D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature, 1997, 389(6653)816-824.
21. Yang, H.Y.; Mitchell, K.; Keller, J.M.; Iadarola, M.J. Peripheral inflammation increases Scya2 expression in sensory ganglia and cytokine and endothelial related gene expression in inflamed tissue. J. Neurochem., 2007, 103(4)1628-1643.
22. Yang, H.Y.; Wilkening, S.; Iadarola, M.J. Spinal cord genes enriched in rat dorsal horn and induced by noxious stimulation identified by subtraction cloning and differential hybridization. Neuro-science, 2001, 103(2)493-502.
23. Basbaum, A.I.; Bautista, D.M.; Scherrer, G.; Julius, D. Cellular and molecular mechanisms of pain. Cell, 2009, 139(2)267-284.
24. Oláh, Z.; Kárai, L.; Iadarola, M.J. Protein kinase C(alpha) is required for vanilloid receptor 1 activation. Evidence for multiple signaling pathways. J. Biol. Chem., 2002, 277(38)35752-35759.
25. Caudle, R.M.; Karai, L.; Mena, N.; Cooper, B.Y; Mannes, A.J.; Perez, F.M.; Iadarola, M.J.; Olah, Z. Resiniferatoxin-induced loss of plasma membrane in vanilloid receptor expressing cells. Neuro-toxicology, 2003, 24(6)895-908.
26. Subramanian, K.; Meyer, T. Calcium-induced restructuring of nuclear envelope and endoplasmic reticulum calcium stores. Cell, 1997, 89(6)963-971.
27. Draisci, G.; Iadarola, M.J. Temporal analysis of increases in c-fos, preprodynorphin and preproenkephalin mRNAs in rat spinal cord. Brain Res. Mol. Brain Res., 1989, 6(1)31-37.
28. Hunt, S.P.; Pini, A.; Evan, G. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature, 1987, 328(6131)632-634.
29. Quinn, J.P.; Takimoto, M.; Iadarola M.; Holbrook, N.; Levens, D. Distinct factors bind the AP-1 consensus sites in gibbon ape leukemia virus and simian virus 40 enhancers. J. Virol., 1989, 63(4)1737-1742.
30. Messersmith, D.J.; Kim, D.J.; Iadarola, M.J. Transcription factor regulation of prodynorphin gene expression following rat hindpaw inflammation. Brain Res. Mol. Brain Res., 1998, 53(1-2)260-269.
31. Noguchi, K.; Kowalski, K.; Traub, R.; Solodkin; Iadarola, M.J.; Ruda, M.A. Dynorphin expression and Fos-like immunoreactivity following inflammation induced hyperalgesia are colocalized in spinal cord neurons. Brain Res Mol Brain Res., 1991, 10(3)227-233.
32. Takahashi, O.; Traub, R.J.; Ruda, M.A. Demonstration of calci-tonin gene-related peptide immunoreactive axons contacting dynorphin A(1-8) immunoreactive spinal neurons in a rat model of peripheral inflammation and hyperalgesia. Brain Res., 1988, 475(1)168-172.
33. Zhang, R.X.; Wang, H.; Ruda, M.; Iadarola, M.J.; Qiao, J.T. c-Fos expression in NMDA receptor-contained neurons in spinal cord in a rat model of inflammation: a double immunocytochemical study. Brain Res., 1998, 795(1-2)282-286.
34. Bates, B.D.; Mitchell, K.; Keller, J.M.; Chan, C.C.; Swaim, W.D.; Yaskovich, R.; Mannes, A.J.; Iadarola, M.J. Prolonged analgesic response of cornea to topical resiniferatoxin, a potent TRPV1 agonist. Pain, 2010, 149(3)522-528
35. Walgenbach, S.C.; Donald, D.E. Cardiopulmonary reflexes and arterial pressure during rest and exercise in dogs. Am. J. Physiol., 1983, 244(Heart Circ. Physiol. 13) H362-H369.
36. Brown, D.C.; Boston, R.C.; Coyne, J.C.; Farrar, J.T. Development and psychometric testing of an instrument designed to measure chronic pain in dogs with osteoarthritis. Am. J. Vet. Res., 2007, 68(6)631-637.
37. Brown, D.C.; Boston, R.C.; Coyne, J.C.; Farrar, J.T. Ability of the canine brief pain inventory to detect response to treatment in dogs with osteoarthritis. J. Am. Vet. Med. Assoc, 2008, 233(8)1278-1283.
38. Brown, D.C.; Boston, R.; Coyne, J.C.; Farrar, J.T. A novel approach to the use of animals in studies of pain: validation of the canine brief pain inventory in canine bone cancer. Pain Med., 2009, 10(1)133-142.
39. Mitchell, K.; Bates, B.D.; Keller, J.M.; Lopez, M.; Scholl, L.; Navarro, J.; Madian, N.; Haspel, G.; Nemenov, M.I.; Iadarola, M.J. Ablation of rat TRPV1-expressing A8-/C-fibers with resinifera-toxin: analysis of withdrawal behaviors, recovery of function and molecular correlates. Mol. Pain, 2010, 17, 6.
40. Daut, R.L.; Cleeland, C.S. The prevalence and severity of pain in cancer. Cancer, 1982, 50(9)1913-1918.
41. Cleeland, C.S.; Gonin, R.; Hatfield, A.K.; Edmonson, J.H.; Blum, R.H.; Stewart, J.A.; Pandya, K.J. Pain and its treatment in outpatients with metastatic cancer. N. Engl. J. Med., 1994, 330(9)592-596.
42. Oster, M.W.; Vizel, M.; Turgeon, L.R. Pain of terminal cancer patients. Arch. Intern. Med., 1978, 138(12)1801-1802
43. Garami, A.; Shimansky, Y.P.; Pakai, E.; Oliveira, D.L.; Gavva, N.R.; Romanovsky, A.A. Contributions of different modes of TRPV1 activation to TRPV1 antagonist-induced hyperthermia. J. Neuroscience, 2010, 30(4)1435-1440.
44. Wong, G.Y.; Gavva, N.R. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks. Brain Res. Rev., 2009, 60(1)267-277.
45. Gavva, N.R. Body-temperature maintenance as the predominant function of the vanilloid receptor TRPV1. Trends Pharmacol Sci., 2008, 29(11)550-557.
46. Mannes, A.J.; Iadarola, M.J. Complete pain relief: potential problems and diagnostic solutions. Nat. Clin. Pract. Neurol., 2007, 3(12)648-649.
47. Mannes, A.; Iadarola, M. Potential downsides of perfect pain relief. Nature, 2007, 446(7131)24.